The leadership team at 23andMe is the driving force behind the company's strategic direction and key decision-making. They are committed to aligning every choice with the company's mission of empowering individuals with access to their genetic information. This team is not just about making decisions; they are about making the right decisions that foster a culture of innovation and growth.
Bringing together expertise from various fields, the leadership team ensures operational excellence and seamless collaboration. Their diverse backgrounds and unified vision create a dynamic environment where new ideas thrive, and the company's goals are consistently met. It's this blend of knowledge and teamwork that propels 23andMe forward in the ever-evolving landscape of genetic research and personalized healthcare.
1) Adam Auton
Adam Auton, the Vice President of Human Genetics at 23andMe, plays a crucial role in overseeing the company's genetic research initiatives. His responsibilities include guiding the scientific team and ensuring the integrity and advancement of genetic studies.
Since joining 23andMe, Adam has made significant contributions, particularly in the areas of statistical genetics and personalized healthcare. His leadership has been instrumental in driving forward key research projects that align with the company's mission.
Adam's extensive background includes roles as a Principal Scientist and Senior Statistical Geneticist at 23andMe, as well as academic positions at Albert Einstein College of Medicine and the University of Oxford. With a PhD in Statistical Genetics from the University of Oxford and an MSc in Physics from the University of Bristol, he brings a wealth of expertise to the organization. For more on the leadership team, visit 23andMe CTO.
2) Anne Wojcicki
Anne Wojcicki, the Co-Founder and CEO of 23andMe, is responsible for steering the company's vision and strategic initiatives. Her expertise in personalized healthcare and genetic research is pivotal to the company's success.
Before founding 23andMe in 2006, Anne gained extensive experience as a healthcare analyst at Passport Capital, Andor Capital Management, and Ardsley Partners. Her background in biology, with a BS from Yale University, complements her analytical skills and deep understanding of the healthcare sector.
Anne's leadership has been instrumental in driving innovative projects that democratize access to genetic information. Her impact on 23andMe is evident in the company's growth and its commitment to empowering individuals through personalized healthcare solutions.
3) Kathy Hibbs
Kathy Hibbs, the Chief Administrative Officer at 23andMe, oversees the company's legal, regulatory, and administrative functions. Her contributions are pivotal in ensuring compliance and streamlining operations within the organization.
With a career spanning several high-profile roles, Kathy has served as Chief Legal and Regulatory Officer at 23andMe and held senior positions at Genomic Health and Monogram Biosciences. Her extensive legal expertise and leadership skills have been instrumental in navigating complex regulatory landscapes.
Kathy manages various teams dedicated to legal affairs, regulatory compliance, and administrative support. She is actively involved in initiatives that enhance operational efficiency and uphold the company's commitment to personalized healthcare.
4) Kenneth Hillan
Kenneth Hillan, the Chief Therapeutics Officer at 23andMe, is responsible for leading the company's therapeutic research and development initiatives. His expertise in medicine and extensive experience in the biotech industry make him a pivotal figure in advancing 23andMe's mission to develop personalized healthcare solutions.
Before joining 23andMe in 2019, Kenneth held several high-profile roles, including President of R&D and Chief Executive Officer at Achaogen, and various senior positions at Genentech. His notable successes include overseeing key projects in immunology and product development, which have significantly contributed to the field of personalized medicine.
5) Jeffrey Pollard
Jeffrey Pollard, the Director of Medical Affairs at 23andMe, plays a pivotal role in overseeing the company's medical strategies and initiatives. His unique contributions include guiding clinical research and ensuring the integration of medical insights into 23andMe's personalized healthcare solutions.
With a robust career history that spans roles such as Co-Founder and Chief Medical Officer at ShadowNurse and Senior Vice President of Medical and Clinical Affairs at Cognoa, Jeffrey brings extensive expertise in medical affairs and clinical research. His notable achievements include leading significant projects in genetic research and personalized medicine, which have greatly advanced 23andMe's mission.
6) Joseph R. Arron
Joseph R. Arron, the Chief Scientific Officer at 23andMe, is responsible for leading the company's scientific research and development efforts. His expertise in immunology and developmental biology plays a crucial role in advancing 23andMe's mission to provide personalized healthcare solutions.
With a distinguished career that includes roles at Genentech and Stanford University, Joseph has made significant contributions to the fields of immunology and genetic research. His leadership and extensive background in both academic and industry settings enable him to effectively guide teams and oversee key projects that drive innovation at 23andMe.
7) Jacquie Cooke Haggarty
Jacquie Cooke Haggarty serves as the General Counsel and Privacy Officer at 23andMe, where she specializes in legal and regulatory compliance, as well as privacy matters. Her role involves overseeing the company's legal strategies and ensuring adherence to privacy regulations.
Jacquie's career journey includes significant roles at WeightWatchers and Genomic Health, where she honed her expertise in commercial and regulatory law. At 23andMe, she has managed various legal departments and contributed to key privacy initiatives, ensuring the company's operations align with legal standards.
8) Steve Lemon
Steve Lemon, the Vice President, Executive Advisor at 23andMe, brings a wealth of experience in engineering and product development to the company. His expertise spans over three decades, with significant contributions to the fields of software development and consumer products.
Before his current role, Steve served as the VP of Engineering at 23andMe, where he led various teams and projects that advanced the company's technological capabilities. His career includes notable positions at companies like Intuit, WebMD, and Apple Computer, showcasing his extensive background in engineering leadership and innovation.
9) Joyce Tung
Joyce Tung, the Vice President of Research at 23andMe, is responsible for overseeing the company's research initiatives and ensuring the scientific integrity of their projects. Her key skills include genetic research and data analysis, which are crucial for driving forward 23andMe's mission of personalized healthcare.
With a Ph.D. in Genetics from the University of California, San Francisco, and a B.S. in Biological Sciences from Stanford University, Joyce brings a wealth of expertise to her role. Since joining 23andMe in 2007, she has held various positions, including Director of Research and Senior Geneticist, significantly contributing to the company's growth and innovation in genetic research.
10) Monica Viziano
Monica Viziano, the Vice President of Portfolio Strategy and Alliance Management at 23andMe, is responsible for overseeing strategic partnerships and managing the company's portfolio of projects. Her role involves aligning business development initiatives with the company's goals to drive growth and innovation.
With a robust background in the pharmaceutical industry, Monica has held various leadership positions at Gilead Sciences and GlaxoSmithKline, where she honed her skills in project and portfolio management. Her extensive experience and strategic vision have significantly contributed to 23andMe's success in personalized healthcare.
23andMe Org Chart
At the top of 23andMe's organizational chart is Co-Founder and CEO Anne Wojcicki, who steers the company's vision and strategic initiatives. Reporting directly to her are key executives including Adam Auton, Vice President of Human Genetics, and Kenneth Hillan, Chief Therapeutics Officer, both of whom drive the company's genetic research and therapeutic development efforts.
Supporting these core functions are Kathy Hibbs, Chief Administrative Officer, and Jacquie Cooke Haggarty, General Counsel and Privacy Officer, who ensure regulatory compliance and legal integrity. Additionally, Joyce Tung, Vice President of Research, and Monica Viziano, Vice President of Portfolio Strategy and Alliance Management, collaborate closely to align research initiatives and strategic partnerships with the company's mission of personalized healthcare.